Change

Consolidated balance sheet


In € millions, December 31

2001

2002

20031

2004

20052

2006

2007

20083

2009

2010

 

 

 

 

 

 

 

 

 

 

 

1

The 2001 – 2003 figures have not been restated to IFRS accounting standards. The differences mainly relate to pensions and other post-retirement benefits, the recognition of deferred taxes on intercompany profit, and the recognition of goodwill.

2

The 2001 – 2005 figures have not been restated for the Organon BioSciences divestment.

3

The 2001 – 2008 figures have not been restated for the National Starch divestment.

Intangible assets

508

629

590

448

488

682

669

7,172

7,388

7,308

Property, plant and equipment

4,568

4,402

3,967

3,535

3,432

3,346

2,203

3,357

3,474

3,384

Financial non-current assets

1,895

2,217

1,866

1,418

1,800

1,706

1,402

1,848

1,783

1,977

Total non-current assets

6,971

7,248

6,423

5,401

5,720

5,734

4,274

12,377

12,645

12,669

Inventories

2,270

2,206

2,133

1,978

1,987

2,042

1,177

1,781

1,441

1,678

Receivables

3,229

2,815

2,671

2,761

2,910

2,919

2,164

2,977

2,666

2,896

Cash and cash equivalents

455

520

727

1,811

1,486

1,871

11,628

1,595

2,128

2,851

Assets held for sale

322

219

4

Total current assets

5,954

5,541

5,531

6,550

6,705

7,051

14,969

6,357

6,235

7,425

Shareholders’ equity

2,878

2,098

2,502

2,605

3,415

4,144

11,032

7,463

7,775

8,984

Minority interests

138

137

140

140

161

119

97

450

470

525

Total equity

3,016

2,235

2,642

2,745

3,576

4,263

11,129

7,913

8,245

9,509

Provisions

2,400

3,855

3,333

2,877

2,210

2,132

1,598

2,072

1,919

1,855

Long-term borrowings

2,235

2,797

2,717

2,392

2,702

2,551

1,954

2,341

3,488

2,880

Other non-current liabilities

560

513

590

200

183

181

133

715

674

589

Total non-current liabilities

5,195

7,165

6,640

5,469

5,095

4,864

3,685

5,128

6,081

5,324

Short-term borrowings

2,267

979

441

560

357

410

1,635

1,338

384

907

Current liabilities

2,447

2,410

2,231

2,677

2,571

2,652

2,276

3,510

3,373

3,761

Current portion of provisions

500

766

571

518

845

797

593

Liabilities held for sale

60

25

Total current liabilities

4,714

3,389

2,672

3,737

3,754

3,658

4,429

5,693

4,554

5,261

Invested capital:

 

 

 

 

 

 

 

 

 

 

– Of consolidated companies

9,395

8,692

8,117

7,145

8,007

8,060

5,197

13,424

11,732

12,718

– Of investments in associates and joint ventures

575

491

353

318

301

177

142

201

175

175

Property, plant and equipment:

 

 

 

 

 

 

 

 

 

 

– Capital expenditures

822

689

581

551

514

371

359

534

513

534

– Depreciation

635

622

599

540

528

349

330

453

424

435

Ratios:

 

 

 

 

 

 

 

 

 

 

Revenue/invested capital

1.52

1.55

1.56

1.68

1.68

1.85

1.91

1.07

1.11

1.15

– Equity/non-current assets

0.43

0.31

0.41

0.51

0.62

0.74

2.60

0.64

0.65

0.75

– Inventories and receivables/current liabilities

2.25

2.08

2.15

1.77

1.9

1.87

1.47

1.36

1.22

1.22

Keyword Search
Copyright © 2011 Akzo Nobel N.V.